An obesity paradox in patients with myocardial infarction undergoing percutaneous intervention

Nutrition, Metabolism and Cardiovascular Diseases - Tập 31 - Trang 127-136 - 2021
Vojko Kanic1, Maja Vollrath2, Barbara Frank1, Zlatka Kanic1
1University Medical Center Maribor, Maribor, Slovenia
2Herzzentrum Leipzig, Leipzig, Germany

Tài liệu tham khảo

Steinberg, 2007, Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get with the Guidelines database, Am J Cardiol, 100, 1331, 10.1016/j.amjcard.2007.06.019 Moscarella, 2017, Impact of body mass index on 5-year clinical outcomes in patients with ST-segment elevation myocardial infarction after everolimus-eluting or bare-metal stent implantation, Am J Cardiol, 120, 1460, 10.1016/j.amjcard.2017.07.040 Bucholz, 2012, Body mass index and mortality in acute myocardial infarction patients, Am J Med, 125, 796, 10.1016/j.amjmed.2012.01.018 Neeland, 2017, The obesity paradox, extreme obesity, and long-term outcomes in older adults with ST-segment elevation myocardial infarction: results from the NCDR, Eur Heart J Qual Care Clin Outcomes, 3, 183, 10.1093/ehjqcco/qcx010 Adams, 2006, Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old, N Engl J Med, 355, 763, 10.1056/NEJMoa055643 Ellis, 1996, Low-normal or excessive body mass index: newly identified and powerful risk factors for death and other complications with percutaneous coronary intervention, Am J Cardiol, 78, 642, 10.1016/S0002-9149(96)00386-4 Song, 2019, The association between body mass index and in-hospital outcome among patients with acute myocardial infarction-Insights from China Acute Myocardial Infarction (CAMI) registry, Nutr Metab Cardiovasc Dis, 29, 808, 10.1016/j.numecd.2019.04.001 Akin, 2012, No evidence of “obesity paradox” after treatment with drug-eluting stents in a routine clinical practice, J Am Coll Cardiol Intv, 5, 162, 10.1016/j.jcin.2011.09.021 Calabrò, 2019, Effect of body mass index on ischemic and bleeding events in patients presenting with acute coronary syndromes (from the START-ANTIPLATELET registry), Am J Cardiol, 124, 1662, 10.1016/j.amjcard.2019.08.030 Carbone, 2019, Obesity paradox in cardiovascular disease: where do we stand?, Vasc Health Risk Manag, 15, 89, 10.2147/VHRM.S168946 Das, 2011, Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-Segment elevation myocardial infarction results from the NCDR (National Cardiovascular Data Registry), J Am Coll Cardiol, 58, 2642, 10.1016/j.jacc.2011.09.030 Elagizi, 2018, An overview and update on obesity and the obesity paradox in cardiovascular diseases, Prog Cardiovasc Dis, 61, 142, 10.1016/j.pcad.2018.07.003 Lamelas, 2017, Effect of body mass index on clinical events after acute coronary syndromes, Am J Cardiol, 120, 1453, 10.1016/j.amjcard.2017.07.043 Oreopoulos, 2008, Effect of obesity on short- and long-term mortality postcoronary revascularization: a meta-analysis, Obesity (Silver Spring), 16, 442, 10.1038/oby.2007.36 Angerås, 2013, Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry, Eur Heart J, 34, 345, 10.1093/eurheartj/ehs217 Romero-Corra, 2006, Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies, Lancet, 368, 666, 10.1016/S0140-6736(06)69251-9 Buettner, 2007, The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction, Eur Heart J, 28, 1694, 10.1093/eurheartj/ehm220 Oreopoulos, 2009, The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH, Eur Heart J, 30, 2584, 10.1093/eurheartj/ehp288 O'Brien, 2014, Association of body mass index and long-term outcomes in older patients with non-ST-segment-elevation myocardial infarction: results from the CRUSADE registry, Circ Cardiovasc Qual Outcomes, 7, 102, 10.1161/CIRCOUTCOMES.113.000421 Kim, 2019, Association between body mass index and 1-year outcome after acute myocardial infarction, PLoS One, 14 Wells, 2006, Relation between body mass index and clinical outcome in acute myocardial infarction, Am J Cardiol, 15, 474, 10.1016/j.amjcard.2006.02.053 Iakobishvili, 2006, Is increased body mass index associated with a cardioprotective effect after ST-segment-elevation myocardial infarction?, Acute Card Care, 8, 95, 10.1080/17482940600768673 Herrmann, 2014, Body mass index and acute and long-term outcomes after acute myocardial infarction (from the harmonizing outcomes with revascularization and stents in acute myocardial infarction trial), Am J Cardiol, 114, 9, 10.1016/j.amjcard.2014.03.057 1998, Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults, Am J Clin Nutr, 68, 899, 10.1093/ajcn/68.4.899 Roffi, 2016, 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation, Eur Heart J, 37, 267, 10.1093/eurheartj/ehv320 Ibanez, 2017, 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, Eur Heart J, 1 Mehran, 2011, Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium, Circulation, 23, 2736, 10.1161/CIRCULATIONAHA.110.009449 Colombo, 2015, Association of obesity and long-term mortality in patients with acute myocardial infarction with and without diabetes mellitus: results from the MONICA/KORA myocardial infarction registry, Cardiovasc Diabetol, 18, 24, 10.1186/s12933-015-0189-0 Stähli, 2016, Impact of body mass index on long-term mortality in women and men undergoing percutaneous coronary intervention for chronic total occlusion, Int J Cardiol, 224, 305, 10.1016/j.ijcard.2016.09.057 Kanic, 2019, Age-specific sex-based differences in anemia in patients with myocardial infarction, J Womens Health (Larchmt), 28, 1004, 10.1089/jwh.2018.7211 Kanic, 2018, Impact of KDIGO-defined acute kidney injury on mortality after percutaneous coronary intervention for acute myocardial infarction, Cardiorenal Med, 8, 332, 10.1159/000492287 Kanic, 2018, Sex-related anemia contributes to disparities in outcome of patients younger than 60 Years with ST-elevation myocardial infarction, J Womens Health (Larchmt), 6, 755, 10.1089/jwh.2017.6644 Carbone, 2019, Obesity, risk of diabetes and role of physical activity, exercise training and cardiorespiratory fitness, Prog Cardiovasc Dis, 62, 327, 10.1016/j.pcad.2019.08.004 Carbone, 2019, The obesity paradox in cardiovascular diseases, J Clin Exerc, 8, 30 Wang, 2018, Obesity paradox in aging: from prevalence to pathophysiology, Prog Cardiovasc Dis, 61, 182, 10.1016/j.pcad.2018.07.011 De Schutter, 2016, The impact of inflammation on the obesity paradox in coronary heart disease, Int J Obes, 40, 1730, 10.1038/ijo.2016.125 Lavie, 2019, Sedentary behavior, exercise, and cardiovascular Health, Circ Res, 124, 799, 10.1161/CIRCRESAHA.118.312669 Modig, 2019, Obesity paradox" holds true for patients with hip fracture: a registry-based, J Bone Joint Surg Am, 101, 888, 10.2106/JBJS.18.01249 Secombe, 2020, Epidemiology and outcomes of obese critically ill patients in Australia and New Zealand, Crit Care Resusc, 22, 35 Yui, 2020, Impact of changes in body mass index after percutaneous coronary intervention on long-term outcomes in patients with coronary artery disease, Heart Ves, 10.1007/s00380-020-01648-3 Piepoli, 2016, Eur Heart J, 37, 2315, 10.1093/eurheartj/ehw106 Carbone, 2019, 5, an opposing point of view on the obesity paradox, Postgrad Med, 131, 333, 10.1080/00325481.2019.1612150